Age-Related Macular Degeneration

Timing of cataract surgery did not affect outcomes among patients with wet age-related macular degeneration, according to a study published in Acta Ophthalmologica.

Patients with neovascular age-related macular degeneration who had treatment delayed due to the COVID-19 pandemic experienced worsening of their disease activity, according to a study.

Jim Williamson, OD, FAAO, FORS, provided an overview of his SECO presentation that focused on evaluating the choroid and differentiating between diseases caused by age-related macular degeneration to those in the pachychoroid spectrum.

The pandemic’s impact on visual hallucinations in people with impaired vision and increased risks for age-related macular degeneration from air pollution led March retina/vitreous coverage on Healio/OSN.

Air pollution is a health hazard, and not only for the lungs.

Although COVID-19 triggered widespread disruption in medical care across all specialties, ophthalmologists had to overcome unique challenges. In an interview with Healio, Rishi P. Singh, MD, discussed problems posed early in the pandemic, the benefits of telemedicine, caring for vulnerable populations in the COVID-19 era and the need for more advanced technology moving forward.

The best source of evidence to base one’s clinical decisions on is a well-designed prospective randomized masked controlled clinical trial.

Patients with age-related macular degeneration who are undergoing cataract surgery should be seen within 4 weeks after surgery and appropriately treated within 14 days if required.

Due to the COVID-19 pandemic, 2020 was marked by innovation and rapid advances in medicine, and the field of ophthalmology was no exception. With the unveiling of important data on age-related macular degeneration at the year’s major conferences, physicians may soon see these changes reflected in clinical practice.

The results of the 2020 Global Trends in Retina Survey reveal a world that is more interconnected and where interactions between groups and individuals in the ophthalmology community increasingly grow across global borders.